A randomized clinical trial of apatinib on an intermittent versus continuous dosing schedule in combination with docetaxel for advanced gastric cancer in second-line setting - Trial in progress

Yifu He, Bing Hu, Ke Li et al.|Annals of Oncology|2018

Cited by 0